Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oberg

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1983
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplicationA Larsson, B Oberg, S Alenius, et al.
Virology|January 10, 1995
Enhancement of HIV-1 proteinase activity by HIV-1 reverse transcriptaseL Goobar-Larsson, B G Luukkonen, T Unge, et al.
AIDS (London, England)|April 1, 1991
Simian immunodeficiency virus (SIVsm) isolation from blood and brain of experimentally infected macaquesD Böttiger, B Keys, P Putkonen, et al.
Plos One|November 13, 2012
Patient-reported experiences with first-time naturopathic care for type 2 diabetesErica B Oberg, Ryan Bradley, Clarissa Hsu, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanineA C Ericson, A Larsson, F Y Aoki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)P Putkonen, K Warstedt, R Thorstensson, et al.
BMC Complementary and Alternative Medicine|April 20, 2012
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one yearRyan Bradley, Karen J Sherman, Sheryl Catz, et al.
International Journal of Cancer|April 15, 1987
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowthN Lewin, P Aman, M G Masucci, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovirA Larsson, K Stenberg, A C Ericson, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|May 1, 1983
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplicationA Larsson, B Oberg, S Alenius, et al.
Virology|January 10, 1995
Enhancement of HIV-1 proteinase activity by HIV-1 reverse transcriptaseL Goobar-Larsson, B G Luukkonen, T Unge, et al.
AIDS (London, England)|April 1, 1991
Simian immunodeficiency virus (SIVsm) isolation from blood and brain of experimentally infected macaquesD Böttiger, B Keys, P Putkonen, et al.
Plos One|November 13, 2012
Patient-reported experiences with first-time naturopathic care for type 2 diabetesErica B Oberg, Ryan Bradley, Clarissa Hsu, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1985
Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanineA C Ericson, A Larsson, F Y Aoki, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)P Putkonen, K Warstedt, R Thorstensson, et al.
BMC Complementary and Alternative Medicine|April 20, 2012
Adjunctive naturopathic care for type 2 diabetes: patient-reported and clinical outcomes after one yearRyan Bradley, Karen J Sherman, Sheryl Catz, et al.
International Journal of Cancer|April 15, 1987
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowthN Lewin, P Aman, M G Masucci, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovirA Larsson, K Stenberg, A C Ericson, et al.
Virology|October 1, 1993
Disruption of a salt bridge between Asp 488 and Lys 465 in HIV-1 reverse transcriptase alters its proteolytic processing and polymerase activityL Goobar-Larsson, K Bäckbro, T Unge, et al.
Pageof 21